Article Versions Notes

Tang J, Liu Q, Du W, Chen L, Qi F, Zhang R, Hoang BH, Geller DS, Yang R, Wang J, et al. Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance. Bioengineering. 2025; 12(6):586. https://doi.org/10.3390/bioengineering12060586

Tang, Junjie, Qian Liu, Wei Du, Linxi Chen, Feiyang Qi, Ranxin Zhang, Bang H. Hoang, David S. Geller, Rui Yang, Jichuan Wang, and et al. 2025. "Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance" Bioengineering 12, no. 6: 586. https://doi.org/10.3390/bioengineering12060586

Tang, J., Liu, Q., Du, W., Chen, L., Qi, F., Zhang, R., Hoang, B. H., Geller, D. S., Yang, R., Wang, J., & Hu, L. (2025). Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance. Bioengineering, 12(6), 586. https://doi.org/10.3390/bioengineering12060586